Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 4601 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Axsome Therapeutics, Inc.

BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  BeyondSpring Inc

Regeneron Provides Update on Biologics License Application for Odronextamab

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Regeneron Pharmaceuticals Inc.

Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Chemomab Therapeutics Ltd.

Manipal Hospital Millers Road Launches Manipal Vriddara Maitri -- A Comprehensive Senior Care Program

Read more ››
By: PR Newswire Association LLC. - 25 Mar 2024

ONO PHARMA Announces Enrollment is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL

Read more ››
By: PR Newswire Association LLC. - 25 Mar 2024

REGENATIVE LABS, WITH ADVANCED MEDICINE OF THE OZARKS, PUBLISHES CASE STUDY DEMONSTRATING UTILIZATION OF WHARTON'S JELLY ALLOGRAFTS IN SUPPLEMENTING CONNECTIVE TISSUE DEFECTS ASSOCIATED WITH TARSAL TUNNEL SYNDROME

Read more ››
By: PR Newswire Association LLC. - 25 Mar 2024

HIPAA Secure Now Pairs Productivity with Cybersecurity Training to Boost Outcomes

Read more ››
By: PR Newswire Association LLC. - 25 Mar 2024

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

Read more ››
By: PR Newswire Association LLC. - 25 Mar 2024
Related companies:  Adagio Medical

Apollo Showcases Digital Pathology Enhancements at USCAP 2024

Read more ››
By: PR Newswire Association LLC. - 25 Mar 2024

First Patient Dosed in Italian Named Patient (Early Access) Program for TLX250-CDx, Telix's Kidney Cancer Imaging Agent

Read more ››
By: PR Newswire Association LLC. - 25 Mar 2024

ARTCLINE successfully completes capital increases of EUR 4.4 million

Read more ››
By: PR Newswire Association LLC. - 25 Mar 2024

ATMA CENA Celebrates Groundbreaking Support from Alberta Blue Cross for Psychedelic-Assisted Therapies

Read more ››
By: PR Newswire Association LLC. - 25 Mar 2024

MediPharm Labs Provides Update on German Cannabis Legalization

Read more ››
By: PR Newswire Association LLC. - 25 Mar 2024
Related companies:  MediPharm Labs Corp.

INNODEM NEUROSCIENCES' ETNA™-MS OBTAINS HEALTH CANADA'S APPROVAL

Read more ››
By: PR Newswire Association LLC. - 25 Mar 2024
Related companies:  Innodem Neurosciences

Health Canada grants approval of the Eye-Tracking Neurological Assessment for Multiple Sclerosis (ETNA™-MS) for use in tracking disease progression in people living with MS

Read more ››
By: PR Newswire Association LLC. - 25 Mar 2024
Related companies:  Novartis Pharmaceuticals Canada Inc.

WELL Health Applauds Improvements in Reimbursement Recently Announced from Key Provinces and Speaks to Improvements in Organic Growth in its Primary Care Business

Read more ››
By: PR Newswire Association LLC. - 25 Mar 2024
Related companies:  WELL Health Technologies Corp.

Industry requests a twelfth stay: 5 years of litigation stays have allowed Big Tobacco to maintain business as usual including recruiting new addicts

Read more ››
By: PR Newswire Association LLC. - 25 Mar 2024

Ultimovacs ASA: Notice of Annual General Meeting on April 18, 2024

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Ultimovacs ASA

Valneva Announces Filing of 2023 Universal Registration Document and US Form 20-F

Read more ››
By: GlobeNewswire - 25 Mar 2024
Related companies:  Valneva SE
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑